SHARES PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic slump today following the unexpected cancellation of its agreement with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending the company's stock price plummeting by over fifteen percent. The reason for the dissolution of the partnership remains unclear, but industry analysts sp